Wallace Stephens

Selected abstracts from the 2019 Annual Meeting of the American Society of Clinical Oncology.

Time to diagnosis, the interval that passes from first symptom presentation until diagnosis, varies by cancer type among children, adolescents, and young adults and may be affected by clinical and sociodemogrpahic factors.

Evidence has shown that nivolumab immunotherapy could effectively treat metastatic renal cell carcinoma (RCC) in settings where resources are constrained.

Regardless of their level of disabilty, patients with multiple sclerosis face a substantial financial burden.

Patterns of chronic obstructive pulmonary disease (COPD) prevalence by geographical location were found to be similar among current, former, and never smokers, indicating factors other than smoking status, such as secondhand smoke exposure, may influence the risk of developing the progressive lung disease.

Researchers at the University of Washington created a tool, which could potentially be developed into an application for smart speakers and smartphones, that uses algorithms and machine learning to identify instances of agonal breathing, a sign of cardiac arrest, with an accuracy of 97% at distances of up to 6 meters away.

"Cocktail therapy," or drug combination treament, may improve quality of life and the conditions of patients with Parkinson disease dementia.

Based upon an agreement that study protocol would be revised, the FDA has removed the partial clinical hold it placed in March on CANOVA, a phase 3 clinical trial of venetoclax.

Coverage from The American Journal of Managed Care's® Institue for Value-Based Medicine® meetings.

Early treatment, in comparison to deferred treatment, of patients with smoldering multiple myeloma could reduce progression and mortality.

According to a meta-analysis, long-term macrolide therapy at low doses could reduce acute exacerbations in patients with chronic obstructive pulmonary disease.

Patients with Parkinson disease appeared to have more than a 2-fold higher risk of developing temporomandibular disorder, known as TMD, in a study that evaluated health insurance data from Taiwan.

Comorbidities, toxicities, and certain treatments received, including immunotherapy and bone marrow transplants, were found to be the strongest predictors of high costs among oncology patients.

Obesity could exacerbate inflammation and worsen clinical disability in patients with relapsing-remitting multiple sclerosis.

A Quest Diagnostics webinar discussed how lab services fit in with value-based care strategies and could reduce total healthcare costs, improve care coordination, and enhance member experiences.

Machine learning, a branch of artificial intelligence, has become more accurate than human medical professionals in predicting incidence of heart attack or death in patients at risk of coronary artery disease.

A new study has found the annual economic burden of Parkinson Disease in the United States is $52 billion, more than double previous estimates.

Alemtuzumab improved clinical and magnetic resonance imagining outcomes in patients with relapsing-remitting multiple sclerosis across varying age groups and maintained efficacy through year 8 of follow up.

Survival of patients with multiple myeloma has continued to improve as treatments have evolved over time.

Abstracts presented at the 2019 American Thoracic Society International Conference suggest that participation in clinical trials and 1-on-1 coaching may improve inhaler technique of patients with chronic obstructive pulmonary disease or other respiratory disorders.

According to 2 abstracts presented at the 2019 American Society of Clinical Oncology Annual Meeting, multimorbidity, insurance status, and income may affect survival rates of patients with multiple myeloma.

Aetion announced the company partnered with Horizon Healthcare Services to identify high-risk patients and optimal treatment pathways as a means to achieve better health outcomes and cut healthcare costs.

Epidemiological evidence suggests that hepatitus C infection may be a risk factor for developing Parkinson disease.

Artificial intelligence (AI) decision support systems could prevent unnecessary cardiac imaging tests for patients suffering from stable chest pain.

The House Appropriation Committee has voted to uphold a ban on genetically modified babies; an assisted suicide bill was passed by the Maine Legislature and will head to the desk of Governor Janet Mills; Beverly Hills has become the first city in the United States to ban sales of tobacco and tobacco-related products.

Results from a new study show that most nicotine-dependent patients with chronic obstructive pulmonary disease (COPD) who attended a 3-month smoking cessation program at a single-center clinic in Japan were able to quit smoking.

Arbaclofen extended-release tablets were found to be a safe treatment that reduced spasticity in patients with multiple sclerosis.

Evidence suggests probiotics may decrease pro-inflammatory cytokines, oxidative stress, and potentially pathogenic bacterial overgrowth in patients with Parkinson disease.

Patients with multiple sclerosis who received natalizumab therapy had lower relapse rates and reduced inflammation.

The addition of daratumumab to standard treatment of lenalidomide and dexamethasone for patients with multiple myeloma, who were ineligible for autologous stem-cell transplant, was found to significantly lower the risk of disease progression or death compared with those who only received standard treatment.